Azitra, Inc. (AZTR) vs Enlivex Ltd. (ENLV)

Azitra, Inc. and Enlivex Ltd. are both Biotechnology companies. Azitra, Inc. and Enlivex Ltd. are of similar size ($4.5M and $4.3M). Enlivex Ltd. trades at the lower P/E: 0.0× against 1.0×. Across the 13 metrics below, Enlivex Ltd. leads on 9 and Azitra, Inc. on 4.

Valuation

Metric AZTR ENLV Biotechnology median
P/E 1.05 0.00 8.50
P/S 2.33 n/m 9.71
P/B 0.18 0.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.48 240.66 0.64
EV/Sales (9.26) n/m 9.21
Earnings yield 95.57% 248,526.43% (33.15%)
Free cash flow yield (842.70%) (301.79%) (25.50%)

Profitability

Metric AZTR ENLV Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (256.67%) 159.77% (56.36%)
Return on assets (190.69%) 127.16% (48.04%)
Return on invested capital (1,272.49%) (5.85%) 0.00%

Growth

Metric AZTR ENLV Biotechnology median
Revenue growth (TTM) 58.18% — 6.02%
EPS growth (last fiscal year) 85.67% 3,590.26% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric AZTR ENLV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.86 119.39 4.72
Net debt to EBITDA 0.20 118.29 0.96

Dividend

Metric AZTR ENLV Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric AZTR ENLV Biotechnology median
Market cap 4.33m 4.46m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack